Physician profile
Jon Orjala
NPI 1265428098
$13,646.52
in general payments reported to CMS, 2019-2025
14 companies · $1,971 in 2025
The $1,971 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,217 · 2020: $1,763 · 2021: $955 · 2022: $1,754 · 2023: $237 · 2024: $749 · 2025: $1,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,887 · Travel and Lodging: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,887.25 |
| Travel and Lodging | $1,069.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,214.60 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix, Na |
| Medacta USA, INC. | $2,677.35 | 2019-2021 | |
| Stryker Corporation | $2,565.10 | 2019-2025 | Champion, Tornier Perform Reversed Glenoid, Blueprint Patient Specific Instrumentation |
| Conformis, INC. | $1,583.34 | 2019-2022 | |
| Davol INC. | $898.48 | 2020-2024 | Arista Ah Flexitip |
| Medtronic USA, INC. | $404.73 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $140.31 | 2022 | |
| Bioventus LLC | $33.41 | 2025 | Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $32.91 | 2022 | |
| Avanos Medical | $23.91 | 2019 | |
| Vericel Corporation | $21.25 | 2024 | Maci |
| Paratek Pharmaceuticals, INC. | $19.27 | 2025 | Xhance |
| Ethicon US, LLC | $17.52 | 2019 | |
| Optinose US, INC. | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Orjala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.